150 related articles for article (PubMed ID: 15308117)
1. Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease.
Maerten P; Geboes K; De Hertogh G; Shen C; Cadot P; Bullens DM; Van Assche G; Penninckx F; Rutgeerts P; Ceuppens JL
Clin Immunol; 2004 Sep; 112(3):239-46. PubMed ID: 15308117
[TBL] [Abstract][Full Text] [Related]
2. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
3. Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
Liu GZ; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmström P; Gao XG
Scand J Immunol; 2006 Oct; 64(4):412-9. PubMed ID: 16970683
[TBL] [Abstract][Full Text] [Related]
4. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
5. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
6. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
[TBL] [Abstract][Full Text] [Related]
7. 4-1BB gene expression in peripheral blood mononuclear cells from orthotopic liver transplant recipients with graft acceptance.
Wan Y; Zheng S; Jia C; Yang J; Jin X; Zhao Z
Chin Med J (Engl); 2003 Dec; 116(12):1854-9. PubMed ID: 14687473
[TBL] [Abstract][Full Text] [Related]
8. Role of 4-1BB in immune responses.
Vinay DS; Kwon BS
Semin Immunol; 1998 Dec; 10(6):481-9. PubMed ID: 9826581
[TBL] [Abstract][Full Text] [Related]
9. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
10. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo.
Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF
Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659
[TBL] [Abstract][Full Text] [Related]
12. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
13. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
Agnholt J; Kaltoft K
Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD137 and CD137 ligand in colorectal cancer patients.
Dimberg J; Hugander A; Wågsäter D
Oncol Rep; 2006 May; 15(5):1197-200. PubMed ID: 16596186
[TBL] [Abstract][Full Text] [Related]
15. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2.
Reali C; Curto M; Sogos V; Scintu F; Pauly S; Schwarz H; Gremo F
J Neurosci Res; 2003 Oct; 74(1):67-73. PubMed ID: 13130507
[TBL] [Abstract][Full Text] [Related]
17. Expression of 4-1BB molecule on peripheral blood T cells in liver transplanted patients and its clinical implication.
Wan YL; Zheng SS; Jia CK; Liang TB; Huang DS; Wang WL; Li MW; Zhao ZC
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):38-43. PubMed ID: 14599927
[TBL] [Abstract][Full Text] [Related]
18. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
[TBL] [Abstract][Full Text] [Related]
19. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biological characterization of human 4-1BB and its ligand.
Alderson MR; Smith CA; Tough TW; Davis-Smith T; Armitage RJ; Falk B; Roux E; Baker E; Sutherland GR; Din WS
Eur J Immunol; 1994 Sep; 24(9):2219-27. PubMed ID: 8088337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
